West Pharmaceutical Services (WST) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Supplies · United States · ISIN US9553061055
West Pharmaceutical Services financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 3.07 bn USD |
| Gross profit | 1.10 bn USD |
| Operating income | 584.90 m USD |
| EBIT | 615.80 m USD |
| Net income | 493.70 m USD |
| Diluted EPS – continuing operations | 6.79 USD |
Full history since 1985, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
More stocks
- DTE Energy (DTE)
- SharkNinja, Inc. (SN)
- Canon Inc (7751.T)
- Ryanair Holdings PLC (RYA.IR)
- Chroma ATE Inc (2360.TW)
- Veolia Environnement SA (VIE.PA)
- Tencent Music Entertainment Group (TME)
- Citizens Financial Group (CFG)
- LARGAN Precision Co Ltd (3008.TW)
- Otis Worldwide (OTIS)
- Inner Mongolia Yili Industrial Group Co Ltd (600887.SS)
- WuXi Biologics (Cayman) Inc (2269.HK)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.